Anna McMahon

Anna McMahon is director of Regulatory Affairs at Cellares.

Articles by Anna McMahon

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Dr. Jeffrey C. Mocny and Cellares’ Anna McMahon

ByFeliza Mirasol,Jeffrey C. Mocny,Anna McMahon

May 12th 2026

Abzena’s Dr. Jeffrey C. Mocny and Cellares’ Anna McMahon discuss how biopharmaceutical risk-based standards accelerate innovation and speed-to-market by leveraging data for better patient outcomes and safety.

Latest Updated Articles

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Dr. Jeffrey C. Mocny and Cellares’ Anna McMahon
May 12th 2026